Meyer Handelman CO Pfizer Inc Transaction History

Meyer Handelman CO

$2.92 Billion
Q3 2024

A detailed history of Meyer Handelman CO transactions in Pfizer Inc stock. As of the latest transaction made, Meyer Handelman CO holds 1,390,406 shares of PFE stock, worth $36.7 Million. This represents 1.38% of its overall portfolio holdings.

Number of Shares

1,390,406

Previous 1,423,218 2.31%

Holding current value

$36.7 Million

Previous $39.8 Million 1.05%

% of portfolio

1.38%

Previous 1.41%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$27.7 - $31.39 $908,892 - $1.03 Million	-32,812 Reduced 2.31%	1,390,406 $40.2 Million
Q2 2024 Jul 16, 2024	SELL	$25.26 - $29.6 $904,434 - $1.06 Million	-35,805 Reduced 2.45%	1,423,218 $39.8 Million
Q1 2024 Apr 11, 2024	BUY	$25.89 - $29.73 $1.36 Million - $1.57 Million	52,682 Added 3.75%	1,459,023 $40.5 Million
Q4 2023 Jan 17, 2024	SELL	$26.13 - $33.94 $1.81 Million - $2.36 Million	-69,412 Reduced 4.7%	1,406,341 $40.5 Million
Q3 2023 Nov 06, 2023	BUY	$32.09 - $37.51 $2.82 Million - $3.29 Million	87,840 Added 6.33%	1,475,753 $49 Million
Q2 2023 Jul 21, 2023	SELL	$36.12 - $41.79 $57,539 - $66,571	-1,593 Reduced 0.11%	1,387,913 $50.9 Million
Q1 2023 Apr 11, 2023	SELL	$39.39 - $51.28 $330,088 - $429,726	-8,380 Reduced 0.6%	1,389,506 $56.7 Million
Q4 2022 Jan 25, 2023	BUY	$41.75 - $54.5 $129,717 - $169,331	3,107 Added 0.22%	1,397,886 $71.6 Million
Q3 2022 Oct 04, 2022	SELL	$43.76 - $53.42 $253,808 - $309,836	-5,800 Reduced 0.41%	1,394,779 $61 Million
Q2 2022 Jul 15, 2022	SELL	$46.53 - $55.17 $245,399 - $290,966	-5,274 Reduced 0.38%	1,400,579 $73.4 Million
Q1 2022 Apr 06, 2022	SELL	$45.75 - $56.69 $686 - $850	-15 Reduced -0.0%	1,405,853 $72.8 Million
Q4 2021 Jan 25, 2022	SELL	$41.32 - $61.25 $17,643 - $26,153	-427 Reduced 0.03%	1,405,868 $83 Million
Q3 2021 Nov 01, 2021	SELL	$39.25 - $50.42 $549,500 - $705,880	-14,000 Reduced 0.99%	1,406,295 $60.5 Million
Q2 2021 Aug 18, 2021	BUY	$35.91 - $40.68 $639,772 - $724,754	17,816 Added 1.27%	1,420,295 $55.6 Million
Q1 2021 May 03, 2021	BUY	$33.49 - $37.77 $1.59 Million - $1.79 Million	47,365 Added 3.5%	1,402,479 $50.8 Million
Q4 2020 Feb 03, 2021	BUY	$33.47 - $42.56 $476,144 - $605,458	14,226 Added 1.06%	1,355,114 $49.9 Million
Q3 2020 Oct 28, 2020	SELL	$31.75 - $37.25 $129,063 - $151,421	-4,065 Reduced 0.3%	1,340,888 $49.2 Million
Q2 2020 Jul 16, 2020	BUY	$30.12 - $36.54 $138,552 - $168,084	4,600 Added 0.34%	1,344,953 $44 Million
Q1 2020 Apr 22, 2020	BUY	$27.03 - $38.62 $109,093 - $155,870	4,036 Added 0.3%	1,340,353 $43.8 Million
Q4 2019 Jan 23, 2020	SELL	$32.92 - $37.36 $474,838 - $538,880	-14,424 Reduced 1.07%	1,336,317 $52.4 Million
Q3 2019 Oct 07, 2019	BUY	$32.49 - $42.13 $126,775 - $164,391	3,902 Added 0.29%	1,350,741 $48.5 Million
Q2 2019 Jul 23, 2019	SELL	$36.98 - $41.52 $3.91 Million - $4.39 Million	-105,700 Reduced 7.28%	1,346,839 $58.3 Million
Q1 2019 Apr 30, 2019	SELL	$37.5 - $41.2 $131,250 - $144,200	-3,500 Reduced 0.24%	1,452,539 $60.3 Million
Q4 2018 Feb 05, 2019	SELL	$38.47 - $43.86 $2.56 Million - $2.92 Million	-66,625 Reduced 4.38%	1,456,039 $63.6 Million
Q3 2018 Nov 06, 2018	SELL	$34.47 - $41.81 $2.26 Million - $2.74 Million	-65,451 Reduced 4.12%	1,522,664 $67.1 Million
Q2 2018 Jul 30, 2018	SELL	$32.98 - $35.16 $359,481 - $383,243	-10,900 Reduced 0.68%	1,588,115 $57.6 Million
Q1 2018 Apr 23, 2018	SELL	$31.91 - $37.02 $350,148 - $406,220	-10,973 Reduced 0.68%	1,599,015 $56.7 Million
Q4 2017 Feb 07, 2018	SELL	$33.26 - $35.29 $4.94 Million - $5.24 Million	-148,422 Reduced 8.44%	1,609,988 $58.3 Million
Q3 2017 Oct 25, 2017	BUY	$31.0 - $34.15 $54.5 Million - $60 Million	1,758,410	1,758,410 $62.8 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meyer Handelman CO, based on Form 13F filings with the SEC.

News

Stay updated on Meyer Handelman CO with notifications on news.

Account

Meyer Handelman CO Pfizer Inc Transaction History